Preston Jeffrey, Cucuzella Mark, Jamieson Barbara
University of Colorado, Denver, CO, USA.
J Fam Pract. 2006 Jul;55(7):631-3.
Inhaled short-acting beta-agonists (SABAs) are most effective in preventing exercise-induced bronchoconstriction, followed by inhaled mast cell stabilizers and anticholinergic agents (strength of recommendation [SOR]: A, multiple randomized control trials [RCTs]). Less evidence supports the use of leukotriene antagonists and inhaled corticosteroids, either individually or in combination (SOR: B). Underlying asthma, which commonly contributes to exercise-induced bronchoconstriction, should be diagnosed and controlled first (SOR: C).
吸入性短效β受体激动剂（SABA）在预防运动诱发性支气管收缩方面最为有效，其次是吸入性肥大细胞稳定剂和抗胆碱能药物（推荐强度[SOR]：A，多项随机对照试验[RCT]）。较少证据支持单独或联合使用白三烯拮抗剂和吸入性糖皮质激素（SOR：B）。通常导致运动诱发性支气管收缩的潜在哮喘应首先得到诊断和控制（SOR：C）。
